Skip to main content
. 2020 Sep 17;144:110275. doi: 10.1016/j.mehy.2020.110275

Table 1.

Compounds identified by interrogating the DSigDB database, using two distinct SARS-CoV-2 – Host interactomes (IA and IB).

Compound Hits
Adjusted p-value
IA IB IA IB
Acetaminophen 95 5 2.03e−4 0.044
Amantadine 7 0.019
Amikacin 30 1.44e−12
Aspirin 21 12 0.003 0.004
Baclofen 15 1.64e−4
Benserazide 6 5 0.002 0.021
Captopril 30 3 2.98e−4 0.023
Cimetidine 40 4.60e−7
Clindamycin 95 18 4.36e−29 0.023
Colchicine 10 0.001
Copper 52 3.27e−5
Dexverapamil 18 1.42e−4
Enalapril 5 0.010
Fluvastatin 5 0.001
Imatinib 5 0.013
Lonafarnib 3 0.018
Losartan 4 0.045
Metoclopramide 11 8.34e−6
Metronidazole 29 1.65e-4
N-Acetyl-Cysteine 7 0.030
Primidone 5 4 0.017 0.026
Selenium 57 22 3.69e−8 0.001
Valproic Acid 175 2.16e−7
Vitamin E 53 22 5.11e−7 0.001
Warfarin 4 0.027
Zinc 17 0.043

IΑ refers to the SARS-CoV-2 – host interactome extracted from Bojkova et al’s study; IB refers to the SARS-CoV-2 – host interactome extracted from Guzzi et al’s study. The order of selection was alphabetical, based on first author name. “Hits” refers to the number of genes comprising each drug – associated signature.